Cellular Models of Alpha-Synuclein Aggregation: What Have We Learned and Implications for Future Study (original) (raw)
Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease
Diana Lázaro
Experimental Neurology, 2017
View PDFchevron_right
Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease
Chuanhai Cao
International Journal of Molecular Sciences
View PDFchevron_right
Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches
Marija Vidovic
Cells
View PDFchevron_right
The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson’s Disease
Ruth Perez, Matthew Benskey, Fredric Manfredsson
View PDFchevron_right
Genetic and Pharmacological Modulation of Alpha-Synuclein Aggregation
Diana Lázaro
2017
View PDFchevron_right
The interplay between Lewy body-like alpha-synuclein aggregates and protein degradation pathways in a cell-based model of Parkinson's disease
Selcuk Tanik
2013
View PDFchevron_right
Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
Laura Marsh
Proceedings of the National Academy of Sciences, 2005
View PDFchevron_right
Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson's Disease Brains Are Differentially Generated in Mammalian Cell Models
Michael Sierks
Biomolecules, 2015
View PDFchevron_right
The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
Oxana Klementieva
Acta Neuropathologica Communications, 2021
View PDFchevron_right
Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications
Marisa Brini
Biological Chemistry, 2017
View PDFchevron_right
Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein
Dominic Hunter
International Journal of Molecular Sciences
View PDFchevron_right
Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation
Horst-W. Korf
Molecular and Cellular Neuroscience, 2003
View PDFchevron_right
Defining α-synuclein species responsible for Parkinson disease phenotypes in mice
Drake Thrasher
Journal of Biological Chemistry
View PDFchevron_right
Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
V. Ghiglieri
Frontiers in neurology, 2018
View PDFchevron_right
Can α-synuclein be targeted in novel therapies for Parkinson’s disease?
Patrik Brundin
Expert Review of Neurotherapeutics, 2011
View PDFchevron_right
Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation
Diana Lázaro
2016
View PDFchevron_right
Both Familial Parkinson's Disease Mutations Accelerate alpha -Synuclein Aggregation
Martin Citron
Journal of Biological Chemistry, 1999
View PDFchevron_right
Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration
Diana Lazaro
Journal of Parkinson's disease, 2013
View PDFchevron_right
Establishment of a human induced pluripotent stem cell neuronal model for identification of modulators of A53T α-synuclein levels and aggregation
Karina Fog
PLOS ONE, 2021
View PDFchevron_right
Physiology and Pathophysiology of α-Synuclein: Cell Culture and Transgenic Animal Models Based on a Parkinson's Disease-associated Protein
Laurence Ozmen
Annals of the New York Academy of Sciences, 2006
View PDFchevron_right
α-synuclein pathogenesis in hiPSC models of Parkinson’s disease
Leo R Quinlan
Neuronal Signaling
View PDFchevron_right
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
Rosario Moratalla
Frontiers in Pharmacology
View PDFchevron_right
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Michael Schlossmacher
npj Parkinson's Disease
View PDFchevron_right
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration HISTORIC PERSPECTIVE OF THE DISCOVERY OF ALPHA-SYNUCLEIN
Diana Lázaro
View PDFchevron_right
Article Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson’s Disease Brains Are Differentially Generated in Mammalian Cell Models
Michael Sierks
2015
View PDFchevron_right
Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
Luis Gerardo Aguayo
Frontiers in Neuroscience, 2015
View PDFchevron_right
Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism
Randall Woltjer, Vivek Unni
Cell reports, 2015
View PDFchevron_right
alpha -Synuclein Fibrillogenesis Is Nucleation-dependent. IMPLICATIONS FOR THE PATHOGENESIS OF PARKINSON'S DISEASE
Martin Citron
Journal of Biological Chemistry, 1999
View PDFchevron_right
α-Synuclein Elevation in Human Neurodegenerative Diseases: Experimental, Pathogenetic, and Therapeutic Implications
Ayse Ulusoy
Molecular Neurobiology, 2013
View PDFchevron_right
A Potential Innovative Therapy for Parkinson’s Disease: Selective Destruction of the Pathological Assemblies of Alpha-Synuclein
Judit Ovádi
2021
View PDFchevron_right
α-Synuclein misfolding and Parkinson's disease
Leonid Breydo, Vladimir Uversky
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
View PDFchevron_right
The Function of α-Synuclein
Jacob Bendor
Neuron, 2013
View PDFchevron_right
Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson’s disease
Natalia Ninkina
Proceedings of the National Academy of Sciences, 2016
View PDFchevron_right
Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles
Rodrigo Acevedo
Frontiers in Neuroscience, 2020
View PDFchevron_right
The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy
Marina Pizzi
Neural plasticity, 2017
View PDFchevron_right